HEALTH

Edgewise Therapeutics' stock rose 15.38% due to promising clinical progress in treating rare muscle disorders, boosting investor confidence and market capitalisation amid a positive biotechnology sector environment.

Erasca Inc. is gaining attention in the biotechnology sector with its focus on RAS/MAPK pathway-driven cancers. Analysts recommend buying amid promising clinical data, despite inherent risks in the field.

Agilent Technologies' shares rose 14% after exceeding Q2 expectations and raising its full-year guidance, driven by strong demand in AI-related applications and growth in life sciences and diagnostics.

Erasca Inc. shares rose nearly 9% as investors responded positively to promising clinical data for its cancer therapy, ERAS-0015, and strategic collaborations aimed at advancing its oncology pipeline.

Fisher & Paykel Healthcare's shares rose over 9% following strong full-year results, driven by global demand for respiratory care products and strategic growth initiatives.

Guardant Health's shares rose over 10% following strong Q1 2026 results and increased revenue guidance, driven by significant growth in oncology and screening revenues.

Roivant Sciences' shares rose significantly after Immunovant's trial of IMVT-1402 showed promising results in treating difficult rheumatoid arthritis, highlighting the company's strong pipeline and financial position.

Immunovant's shares rose significantly after reporting positive trial data for IMVT-1402 in rheumatoid arthritis, despite a wider net loss. The promising results highlight potential for deeper IgG reduction.

Daraxonrasib, a new drug targeting the KRAS mutation in pancreatic cancer, shows potential to double survival times, generating high demand and cautious optimism among patients and oncologists.

SYDNEY — Australia's healthcare sector enters 2026 amid robust growth in digital and wellness markets, significant public hospital funding boosts and private health insurance premium hikes that have consumers rethinking coverage, as the system grapples with an aging population, chronic disease pressures and calls for deeper preventive care reforms.

ImmunityBio Inc.'s stock has skyrocketed in early 2026, surging more than 500% year-to-date and hitting new 52-week highs above $11 as explosive sales growth for its flagship immunotherapy ANKTIVA, coupled with rapid international regulatory approvals and partnerships, fuels investor enthusiasm for the cancer-focused biotech.

Hims & Hers Health Inc. (NYSE: HIMS) shares tumbled sharply in trading on Tuesday, February 24, 2026, falling as much as 9%

Dr. Fauci has again praised Australia for its successful handling of the COVID-19 pandemic and containing the spread of the virus.

An Italian priest has died of COVID-19 after giving his respirator to a younger patient in a hospital at Lovere Bergamo, northern Italy.

This generation is also called the millennials and starting with 2015, they are the workforce majority of the world.

Rubella has been eliminated in Australia, the World Health Organisation confirmed on Wednesday.

In recent developments, many pet owners are using cannabidiol (CBD) products as a cure-all for their furry companions.

The mothers in the Dutch experiment were also taking Sildenafil, a drug sold as Viagra.

The previously proposed Medicare levy has been scrapped.

Greg Hunt has argued gay conversion therapy is a matter of freedom of speech.

A tissue-destroying.ulcer, commonly in the tropical regions of West or Central Africa, is on the rise in Victoria.

There is growing concern about whether or not they are able to implement a sustainable method in harvesting the plant.

The first licensed imports of cannabis have arrived in Perth, and seriously ill Australians can now access the imported medical marijuana. The drug has been imported Down Under in a joint collaboration between Swiss cannabis company Creso Pharma and Australian wholesale company Health House International.

Researchers have found out that drinkers who mix energy drinks with alcoholic beverages may be more likely to have increased risk of injury.

A method that can bolster memory similar to what champions have was underscored by a team of research scientists.

The Australian Council of Social Service (ACOSS) has created a budget proposal that would require all high earners to pay a Medicare levy surcharge.

Medibank health insurance has blamed IT glitches for its 102 debit problems in the last quarter of 2016.

Boston University scientists have revealed that they have developed a blood test that can predict lifespans. As weird as it may sound, the scientists believe it is a game-changing blood test though the test needs to be conducted on larger groups of people to confirm the results. This breakthrough will allow patients to identify health risks early on and subsequently modify behaviour to change outcome.

The anti-cancer drug Venetoclax has just received Australia approval. The drug was developed by a team of international and Australian scientists and now it has been reported that the drug can “melt away” certain advanced forms of chronic lymphocytic leukaemia (CLL).